The FASEB Journal,
Journal Year:
2024,
Volume and Issue:
38(14)
Published: July 11, 2024
Abstract
DUX4
has
been
widely
reported
in
facioscapulohumeral
muscular
dystrophy,
but
its
role
Duchenne
dystrophy
(DMD)
is
unclear.
Dux
the
mouse
paralog
of
DUX4.
In
−/−
mdx
mice,
forelimb
grip
strength
test
and
treadmill
were
performed,
extensor
digitorum
longus
(EDL)
contraction
properties
measured
to
assess
skeletal
muscle
function.
Pathological
changes
mice
determined
by
serum
CK
LDH
levels
Masson
staining.
Inflammatory
factors,
oxidative
stress,
mitochondrial
function
indicators
detected
using
kits.
Primary
satellite
cells
isolated,
antioxidant
molecule
Nrf2
was
detected.
MTT
assay
Edu
used
evaluate
proliferation
TUNEL
for
cell
death.
The
results
show
that
deletion
enhanced
EDL
contractility,
prolonged
running
time
distance
mice.
Deleting
also
attenuated
fibrosis,
inflammation,
dysfunction
Furthermore,
deficiency
promoted
survival
increasing
Orphanet Journal of Rare Diseases,
Journal Year:
2021,
Volume and Issue:
16(1)
Published: March 4, 2021
Abstract
Background
Pharmacological
corticosteroid
therapy
is
the
standard
of
care
in
Duchenne
Muscular
Dystrophy
(DMD)
that
aims
to
control
symptoms
and
slow
disease
progression
through
potent
anti-inflammatory
action.
However,
a
major
concern
significant
adverse
effects
associated
with
long
term-use.
Main
This
review
discusses
pros
cons
treatment
for
DMD
compares
it
novel
data
generated
new-wave
dissociative
corticosteroid,
vamorolone.
The
current
status
experimental
pharmaceuticals
also
reviewed,
insights
regarding
alternative
drugs
could
provide
therapeutic
advantage.
Conclusions
Although
steroids
may
be
superior
substitutes
corticosteroids,
other
potential
therapeutics
should
explored.
Repurposing
or
developing
pharmacological
therapies
capable
addressing
many
pathogenic
features
addition
anti-inflammation
elicit
greater
advantages.
Cells,
Journal Year:
2024,
Volume and Issue:
13(7), P. 574 - 574
Published: March 26, 2024
Duchenne
muscular
dystrophy
(DMD)
is
a
genetic
progressive
muscle-wasting
disorder
that
leads
to
rapid
loss
of
mobility
and
premature
death.
The
absence
functional
dystrophin
in
DMD
patients
reduces
sarcolemma
stiffness
increases
contraction
damage,
triggering
cascade
events
leading
muscle
cell
degeneration,
chronic
inflammation,
deposition
fibrotic
adipose
tissue.
Efforts
the
last
decade
have
led
clinical
approval
novel
drugs
for
aim
restore
function.
However,
combination
therapies
able
expression
target
myriad
cellular
found
impaired
dystrophic
are
desirable.
Muscles
higher
energy
consumers
susceptible
mitochondrial
defects.
Mitochondria
generate
significant
source
reactive
oxygen
species
(ROS),
they
are,
turn,
sensitive
proper
redox
balance.
In
both
animal
models
there
compelling
evidence
impairments
key
role
failure
homeostasis.
Here,
we
highlighted
main
aspects
dysfunction
oxidative
stress
discussed
recent
findings
linked
mitochondria/ROS-targeted
molecules
as
therapeutic
approach.
this
respect,
dual
targeting
mitochondria
homeostasis
emerges
potential
option
DMD.
Oxidative Medicine and Cellular Longevity,
Journal Year:
2021,
Volume and Issue:
2021(1)
Published: Jan. 1, 2021
Saccharomyces
boulardii
(
S.
)
is
a
probiotic
yeast
that
widely
used
to
treat
gastrointestinal
disorders.
The
present
study
aimed
explore
the
therapeutic
effects
of
on
dextran
sulfate
sodium‐
(DSS‐)
induced
murine
ulcerative
colitis
(UC)
and
illustrate
mechanisms
action.
C57BL/6
mice
were
administered
(10
5
10
7
CFU/ml,
p.o.
for
3
weeks
then
given
DSS
[2.5%
w
/
v
)]
one
week.
Administration
prevented
DSS‐induced
reduction
in
body
weight,
diarrhea,
bloody
feces,
decreased
colon
length,
loss
histological
structure.
Moreover,
protected
intestinal
barrier
by
increasing
levels
tight
junction
proteins
zona
occludens‐1
Occludin
exerted
immunomodulatory
mice.
Furthermore,
suppressed
colonic
inflammation
reducing
Interleukin‐1
β
,
Interleukin‐6,
Tumor
necrosis
factor
alpha
restored
myeloperoxidase
activity
exposed
DSS.
also
mitigated
oxidative
damage
antioxidant
enzymes
(superoxide
dismutase,
catalase,
heme
oxygenase
1)
glutathione
decreasing
malondialdehyde
accumulation.
Further
studies
identified
nuclear
translocation
kappa
B
(NF‐
κ
B)
p65
subunit
I
K
α
levels,
while
promoted
erythroid
2‐related
2
(Nrf2)
DSS‐exposed
Collectively,
possessed
an
appreciable
effect
against
experimental
model
UC.
protective
mechanism
may
involve
inhibition
NF‐
B‐mediated
proinflammatory
signaling
activation
Nrf2‐modulated
defense
addition
effects.
Frontiers in Cellular Neuroscience,
Journal Year:
2021,
Volume and Issue:
15
Published: Nov. 26, 2021
Inherited
metabolic
disorders
(IMDs)
are
rare
genetic
conditions
that
affect
multiple
organs,
predominantly
the
central
nervous
system.
Since
treatment
for
a
large
number
of
IMDs
is
limited,
there
an
urgent
need
to
find
novel
therapeutical
targets.
Nuclear
factor
erythroid-2-related
2
(Nrf2)
transcription
has
key
role
in
controlling
intracellular
redox
environment
by
regulating
expression
antioxidant
enzymes
and
several
important
genes
related
homeostasis.
Considering
oxidative
stress
along
with
system
alterations
mechanism
involved
neuropathophysiology
many
IMDs,
this
review
focuses
on
current
knowledge
about
Nrf2
signaling
dysregulation
observed
group
characterized
neurological
dysfunction.
We
here
X-linked
adrenoleukodystrophy,
glutaric
acidemia
type
I,
hyperhomocysteinemia,
Friedreich’s
ataxia.
Additionally,
beneficial
effects
different
activators
shown,
identifying
promising
target
patients
these
disorders.
expect
article
stimulates
research
into
investigation
pathway
involvement
use
potential
pharmacological
modulators
counteract
exert
neuroprotection.
Cells,
Journal Year:
2021,
Volume and Issue:
10(6), P. 1364 - 1364
Published: June 1, 2021
In
recent
years,
growing
evidence
has
suggested
a
prominent
role
of
oxidative
stress
in
the
pathophysiology
several
early-
and
adult-onset
muscle
disorders,
although
effective
antioxidant
treatments
are
still
lacking.
Oxidative
causes
cell
damage
by
affecting
protein
function,
membrane
structure,
lipid
metabolism,
DNA
integrity,
thus
interfering
with
skeletal
homeostasis
functionality.
Some
features
related
to
stress,
such
as
chronic
inflammation,
defective
regeneration,
mitochondrial
shared
among
most
muscular
dystrophies,
Nrf2
been
shown
be
central
player
antagonizing
redox
imbalance
these
disorders.
However,
exact
mechanisms
leading
overproduction
reactive
oxygen
species
deregulation
cellular
antioxidants
system
seem
be,
large
extent,
disease-specific,
clarification
vivo
humans
is
cornerstone
for
development
targeted
therapies,
which
will
require
testing
appropriately
designed
clinical
trials.
The Journal of Physiology,
Journal Year:
2024,
Volume and Issue:
602(11), P. 2627 - 2648
Published: May 23, 2024
Homeostasis
constitutes
a
key
concept
in
physiology
and
refers
to
self-regulating
processes
that
maintain
internal
stability
when
adjusting
changing
external
conditions.
It
diminishes
entropy
constituting
driving
force
behind
evolution.
Natural
selection
might
act
on
homeostatic
regulatory
mechanisms
control
including
homeodynamics,
allostasis,
hormesis
homeorhesis,
where
different
stable
stationary
states
are
reached.
Regeneration
is
under
through
hormesis.
Damage
tissues
initiates
response
restore
the
impaired
equilibrium
caused
by
mild
stress
using
cell
proliferation,
differentiation
death
recover
structure
function.
Repair
homeorhetic
change
leading
new
state
with
decreased
functionality
fibrotic
scarring
without
reconstruction
of
3-D
pattern.
Mechanisms
determining
entrance
tissue
or
organ
regeneration
repair
include
balance
between
innate
adaptive
immune
cells
relation
plasticity
stromal
stem
responses,
redox
balance.
The
regenerative
reparative
capacities
vary
species,
distinct
organs,
at
stages
development
ageing.
Many
signals
pathways
play
crucial
roles
regulating
protein
synthesis,
cellular
growth,
inflammation,
autophagy,
lysosomal
function,
metabolism
metalloproteinase
signalling.
Attempts
favour
damaged
those
low
proliferative
rates
have
been
made;
however,
there
evolutionary
constraint
poor
proliferation
unfavourable
environments
tumour
development.
More
research
required
better
understand
these
mechanisms.
Pharmaceuticals,
Journal Year:
2020,
Volume and Issue:
14(1), P. 15 - 15
Published: Dec. 26, 2020
COVID-19
has
rapidly
spread
worldwide
and
incidences
of
hospitalisation
from
respiratory
distress
are
significant.
While
a
vaccine
is
in
the
pipeline,
there
urgency
for
therapeutic
options
to
address
immune
dysregulation,
hyperinflammation
oxidative
stress
that
can
lead
death.
Given
shared
pathogenesis
severe
cases
with
aspects
multiple
sclerosis
psoriasis,
we
propose
dimethyl
fumarate
as
viable
treatment
option.
Currently
approved
an
immunomodulatory,
anti-inflammatory
anti-oxidative
drug
could
be
implemented
into
clinic
calm
cytokine
storm
which
drives
COVID-19.